Enterovirus A vaccine - Sinovac Biotech
Alternative Names: EV-71; EV-71-vaccine; EV71 vaccine - Sinovac; Inlive; Vero CellLatest Information Update: 22 Aug 2024
Price :
$50 *
At a glance
- Originator Sinovac Biotech
- Class Enterovirus vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Enterovirus A infections
Most Recent Events
- 30 Jun 2024 Registered for Enterovirus A infections (In children, In infants, Prevention) in Macau (IV), prior to June 2024
- 17 Nov 2022 Registered for Enterovirus A infections (In children, In infants, Prevention) in Indonesia (IV)
- 02 Jun 2022 Sinovac Biotech plans a phase-III trial for Enterovirus A infection (In children, in infants, Prevention) in China in July 2022 (IV) (NCT05397587)